Attached files

file filename
EX-10.141 - NTS, INC.ex10141.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

FORM 8-K/A
(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 1, 2010 (May 14, 2010)
 
XFONE, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
(State or other jurisdiction of incorporation or organization)
 
Commission File No. 001-32521
 
11-3618510
(I.R.S. Employer Identification Number)
 
5307 W. Loop 289
Lubbock, Texas 79414
 (Address of principal executive offices) (Zip Code)
 
806-771-5212
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
-1-

 
Item 1.01                      Entry into a Material Definitive Agreement

As previously disclosed on a Current Report on Form 8-K dated May 14, 2010 (the “Initial 8-K”), on May 14, 2010 Xfone, Inc. (the “Company’) entered into a contract (the “Contract”) with Newcall Ltd., the Company’s 26% minority interest partner (the “Minority Partner”) in the Company’s Israeli-based subsidiary, Xfone 018 Ltd. (“Xfone 018”), and Marathon Telecom Ltd. (“Marathon Telecom”), for the sale by the Company of its 69% interest in Xfone 018, and the sale by the Minority Partner of its 26% interest in Xfone 018 (collectively, the “Holdings”) to Marathon Telecom (the “Transaction”).   Subsequently, the owner of the remaining 5% interests in Xfone 018, Margo Pharma Ltd., became a party to the Contract for the sale of its interests in Xfone 018 to Marathon Telecom.

The Contract was signed in Hebrew, and an English translation of the Contract was unavailable at the time of the filing of the Initial 8-K.  This Current Report on Form 8-K/A amends the Initial 8-K to file the English translation of the Contract as Exhibit 10.141.

Item 9.01                       Financial Statements and Exhibits

(a)            Not applicable.
(b)            Not applicable.
(c)            Not applicable.
(d)            Exhibits.

Exhibit No.
Description
10.141
Contract dated May 14, 2010 by and between Xfone, Inc., Newcall Ltd., Margo Pharma, Ltd., and Marathon Telecom Ltd. [English translation]
 
 
-2-

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

       
 
Xfone, Inc.            
 
       
Date: June 1, 2010
By:  
/s/  Guy Nissenson
 
 
Guy Nissenson
 
 
President, Chief Executive Officer and Director
 

 
-3-

 
INDEX TO EXHIBITS


Exhibit No.
Description
10.141
Contract dated May 14, 2010 by and between Xfone, Inc., Newcall Ltd., Margo Pharma, Ltd., and Marathon Telecom Ltd. [English translation]

 
-4-